SEC Form D filing

Liminatus Pharma, Inc., 2026-06-18

An SEC Form D private-offering notice from Fullerton, CA, a $1,861,920 filer-stated offering target in Biotech. Filed 2026-06-18. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Liminatus Pharma, Inc. site↗ Verified via SEC Form D

Nasdaq listed preclinical stage immuno oncology biopharmaceutical company developing IBA101, a CD47 blockade antibody for solid tumors.

Filed 2026-06-18Filed to raise $1,861,920First money in 2026-06-03Raised so far $1,861,920HQ (as filed) Fullerton, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified liminatuspharma.com↗Named in the filing 8 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source